Chargement en cours...
A Retrospective Analysis of Sociodemographic and Hematologic Characteristics Associated with Achieving Optimal Hydroxyurea Therapy in Children with Sickle Cell Disease
Hydroxyurea (HU) has proven hematologic and clinical benefits, especially when escalated to the maximum tolerated dose (MTD). We reviewed clinical data from patients with sickle cell disease (SCD) (1/2011–1/2016) to determine baseline sociodemographic and laboratory parameters associated with reachi...
Enregistré dans:
| Publié dans: | J Pediatr Hematol Oncol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6019152/ https://ncbi.nlm.nih.gov/pubmed/29683954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000001177 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|